Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus

Journal of Lipid Research

Volumn 49, Issue 7, 2008, Pages 1438-1444

  Tan, Kathryn C B ^a   Shiu, Sammy W M ^a   Wong, Ying ^a   Leng, Lin ^b   Bucala, Richard ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced glycation end products; Oxidized LDL; Soluble receptors

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SULFONYLUREA;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; BLOOD; MIDDLE AGED; SOLUBILITY;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; SCAVENGER RECEPTORS, CLASS E; SOLUBILITY;

EID: 50949106121     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700551-JLR200     Document Type: Article

References (26)

1. Sawamura, T., N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, et al. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386: 73-77.
2. Yoshida, H., N. Kondratenko, S. Green, D. Steinberg, and O. Quehenberger. 1998. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J. 334: 9-13.
3. Vohra, R. S., J. E. Murphy, J. H. Walker, S. Ponnambalam, and S. Homer-Vanniasinkam. 2006. Atherosclerosis and the lectin-like oxidized low-density lipoprotein scavenger receptor. Trends Cardiovasc. Med. 16: 60-64.
4. Mehta, J. L., J. Chen, P. L. Hermonat, F. Romeo, and G. Novelli. 2006. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc. Res. 69: 36-45.
5. Chen, M., M. Kakutani, M. Minami, H. Kataoka, N. Kume, S. Narumiya, T. Kita, T. Masaki, and T. Sawamura. 2000. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 20: 1107-1115.
6. Kataoka, H., N. Kume, S. Miyamoto, M. Minami, H. Moriwaki, T. Murase, T. Sawamura, T. Masaki, N. Hashimoto, and T. Kita. 1999. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 99: 3110-3117.
7. Li, D., and J. L. Mehta. 2000. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 101: 2889-2895.
8. Cominacini, L., A. F. Pasini, U. Garbin, A. Davoli, M. L. Tosetti, M. Campagnola, A. Rigoni, A. M. Pastorino, V. Lo Cascio, and T. Sawamura. 2000. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J. Biol. Chem. 275: 12633-12638.
9. Cominacini, L., A. Fratta Pasini, U. Garbin, A. Pastorino, A. Rigoni, C. Nava, A. Davoli, V. Lo Cascio, and T. Sawamura. 2003. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J. Am. Coll. Cardiol. 41: 499-507.
10. Kume, N., T. Murase, H. Moriwaki, T. Aoyama, T. Sawamura, T. Masaki, and T. Kita. 1998. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ. Res. 83: 322-327.
11. Li, D., and J. L. Mehta. 2000. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler. Thromb. Vasc. Biol. 20: 1116-1122.
12. Li, L., T. Sawamura, and G. Renier. 2003. Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes. 52: 1843-1850.
13. Li, L., T. Sawamura, and G. Renier. 2004. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ. Res. 94: 892-901.
14. Jono, T., A. Miyazaki, R. Nagai, T. Sawamura, T. Kitamura, and S. Horiuchi. 2002. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett. 511: 170-174.
15. Chen, M., M. Nagase, T. Fujita, S. Narumiya, T. Masaki, and T. Sawamura. 2001. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. Biochem. Biophys. Res. Commun. 287: 962-968.
16. Iwashima, Y., M. Eto, A. Hata, K. Kaku, S. Horiuchi, F. Ushikubi, and H. Sano. 2000. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 277: 368-380.
17. Murase, T., N. Kume, H. Kataoka, M. Minami, T. Sawamura, T. Masaki, and T. Kita. 2000. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler. Thromb. Vasc. Biol. 20: 715-720.
18. Hayashida, K., N. Kume, T. Murase, M. Minami, D. Nakagawa, T. Inada, M. Tanaka, A. Ueda, G. Kominami, H. Kambara, et al. 2005. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation. 112: 812-818.
19. Makita, Z., H. Vlassara, A. Cerami, and R. Bucala. 1992. Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267: 5133-5138.
20. Tan, K. C. B., W. S. Chow, V. H. G. Ai, C. Metz, R. Bucala, and K. S. L. Lam. 2002. Advanced glycation end products and endothelial dysfunction in type 2 diabetes mellitus. Diabetes Care. 25: 1055-1059.
21. Al-Abed, Y., and R. Bucala. 2000. Structure of a synthetic glucose derived advanced glycation end-product that is immunologically cross-reactive with its naturally occurring counterparts. Bioconjug. Chem. 11: 39-45.
22. Shi, X., S. Niimi, T. Ohtani, and S. Machida. 2001. Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J. Cell Sci. 114: 1273-1282.
23. Pennathur, S., and J. W. Heinecke. 2007. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid. Redox Signal. 9: 955-969.
24. Hartge, M. M., T. Unger, and U. Kintscher. 2007. The endothelium and vascular inflammation in diabetes. Diabetes Vasc. Dis. Res. 4: 84-88.
25. Tan, K. C. B., S. W. M. Shiu, Y. Wong, and S. Tam. 2005. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. Atherosclerosis. 178: 365-370.
26. Lautamäki, R., T. Rönnemaa, R. Huupponen, T. Lehtimäki, P. Iozzo, K. E. Airaksinen, J. Knuuti, and P. Nuutila. 2007. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease. Metabolism. 56: 881-886.